Central Bank leaves refinancing rate unchanged taking into account high uncertainty in US economic policy

YEREVAN, May 6. /ARКА/. The Central Bank of Armenia decided today to leave the refinancing rate unchanged at 6.75% taking into account a set of factors such as  the continued high uncertainty surrounding the US economic policy, declining confidence in the global economy, growth slowdown and  a possible  weakening demand in Armenia, the head of the regulator Martin Galstyan said at a press conference on Tuesday.

According to him, these factors underlie Scenario B – one of the two scenarios that the Central Bank relies on when determining the refinancing rate.

According to Galstyan, Scenario A is based on uncertainties, including factors related to geopolitics and the fiscal policy.

“These uncertainties  require higher interest rates than market expectations to ensure price stability,” he said, adding that the regulator sees the need to manage the significant macroeconomic implications that follow from this scenario. -0-

spot_img

POPULAR

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

An Armenian Business Founded in a Garage: Games for Live Communication with the Support of Acba Bank

The success story of board games created by David Hovhannisyan began in a small garage near his home. David and his friends created educational games during their student years; as the number of orders grew, they decided to expand the business.

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

LATEST NEWS

spot_imgspot_imgspot_img